Targeted Cancer Therapy

Links to news articles on Targeted Cancer Therapy .

Diatos Announces Expansion of Medarex Cancer Product Licensing ... -- Mar 28, 2006
...company, announced today that Medarex has granted full European commercialization rights for DTS-201 (a doxorubicin prodrug for targeted cancer therapy) to ... Yahoo! News (press release)

New Therapies Target Cancer -- Mar 7, 2006
..."Gleevec was the first targeted cancer therapy developed based on knowledge that came from understanding the genetic basis of the disease," says Armstrong. ... Drug Discovery & Development (subscription),

GenVec Reports Fourth Quarter and 2005 Year End Financial Results -- Mar 15, 2006
...of Japan to identify a targeted cancer therapy to treat not only the primary tumor but also cancer that has metastasized to distant sites in the body ($1.6 ... Genetic Engineering News,

TRACON Pharmaceuticals Assembles Industry-Leading Management Team ... -- Mar 15, 2006
SAN DIEGO, March 15 /PRNewswire/ -- TRACON Pharmaceuticals, Inc., an emerging biopharmaceutical company developing targeted cancer therapies, today announced ... Yahoo! News (press release)

Books and Media Received -- Mar 7, 2006
Advances in Targeted Cancer Therapy edited by Richard M. Schultz (Progress in Drug Research), 303 pp, with illus, $249, ISBN 3-7643-7174-9, Basel, Switzerland ... Journal of American Medical Association (subscription),

(PRN) - Pennsylvania Governor Rendell Awards $1.6 Million to Help ... -- Mar 15, 2006
...[+]. (PRN) - TRACON Pharmaceuticals Assembles Industry-Leading Management Team to Support Development of Targeted Cancer Therapy Pipeline ... [+. ... Bolsamania.com,

Promising Target For Cancer Therapies Validated In New Study -- Jan 2, 2006
Temple University Researchers Develop New Targeted Cancer Therapy (April 10, 2005) -- Temple University researchers have developed a new drug that halts cancer ... Science Daily (press release)

Merck KGaA Receives Approval for Erbitux in Head and Neck Cancer -- Dec 22, 2005
...today that Swissmedic, the Swiss Agency for Therapeutic Products, has granted marketing authorization to extend the use of the targeted cancer therapy, Erbitux ... PharmaLive.com (press release),

A new study gives credence to "targeted" cancer therapy -- Dec 16, 2005
An alternative to traditional radiation could allow some breast cancer patients to be treated in less time, according to a small study presented in Denver at ... Asbury Park Press,

Woman wins right to fight for new breast cancer drug -- Dec 21, 2005
The drug, a completely new type of targeted cancer therapy, costs about Ā£19,500 for one patient for a one-year course of treatment. ... Telegraph.co.uk,

View Profiles of 165 Companies Involved in Developing Innovative ... -- Dec 15, 2005
...formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer approaches to cancer treatment ... PharmaLive.com (press release),

Gene mapping project promises new targeted cancer therapies -- Dec 14, 2005
...week launched a pilot project to find all the little genetic changes that cause cancer in the hope it will lead to a whole new world of targeted cancer therapy ... News-Medical.net,

Don Peasley -- Dec 17, 2005
...research. "Advances in Targeted Cancer Therapy" reflects major advances in the understanding of molecular and tumor biology. Richard ... Northwest Herald,

US launches cancer gene mapping project -- Dec 13, 2005
...launched on Tuesday a pilot project to find all the little genetic changes that cause cancer and hope it can open a whole new world of targeted cancer therapy. ... Reuters

New Cancer Research May Be Door-Opener -- Dec 14, 2005
...cancer. They are hoping, in its success, that it will open up a stage of targeted cancer therapy, according to published reports. ... Post Chronicle

Immunomedics shares rise on pending deal -- Dec 15, 2005
Piros added in a report that Amgen Inc.'s decision to buy Abgenix Inc., which is developing a targeted cancer therapy called panitumumab, "indicates that ... BusinessWeek

Monogram's eTag(TM) Technology Featured in British Journal of ... -- Dec 1, 2005
...confirm the results of initial studies; whether the results of studies conducted with patient samples treated with a particular targeted cancer therapy will be ... PR Newswire (press release),

Monogram Presents Clinical Data on eTag(TM) Assay's Potential to ... -- Nov 15, 2005
...confirm the results of initial studies; whether the results of studies conducted with patient samples treated with a particular targeted cancer therapy will be ... Yahoo! News (press release)

Merck KGaA Advances Phase III Clinical Trial Program for Erbitux -- Nov 2, 2005
ECCO) that recruitment has been completed for its global phase III clinical trial, CRYSTAL, examining first-line use of the targeted cancer therapy Erbitux ... PharmaLive.com (press release),

Active Biotech Interim report January ā€“ September 2005 -- Nov 2, 2005
...normal tissue in patients. This is a significant milestone in the development of a targeted cancer therapy. These results are part ... Biotech Intelligence (press release),

OXFORD BIOMEDICA PLC ANNOUNCES WYETH PRECLINICAL DATA -- Oct 18, 2005
The 5T4 antibody-targeted cancer therapy is being developed by Wyeth Pharmaceuticals, which licensed rights to Oxford BioMedica's antibody against the tumour ... Market Wire (press release)

OXFORD BIOMEDICA announces presentation by wyeth Pharmaceuticals ... -- Oct 19, 2005
The 5T4 antibody-targeted cancer therapy is being developed by Wyeth Pharmaceuticals, which licensed rights to Oxford BioMedicaā€™s antibody against the tumour ... Biotech Intelligence (press release),

GenVec Reports Third Quarter 2005 Financial Results; Vaccine ... -- Nov 2, 2005
...of clinical grade vaccine candidates, and from our collaboration with Fuso Pharmaceutical Industries for the development of a targeted cancer therapy. ... Genetic Engineering News,

More information on Targeted Cancer Therapy from the National Cancer Institute

Targeted cancer therapies use drugs that block the growth and spread of cancer. They interfere with specific molecules involved in carcinogenesis (the process by which normal cells become cancer cells) and tumor growth. Because scientists call these molecules “molecular targets,” these therapies are sometimes called “molecular-targeted drugs,” “molecularly targeted therapies,” or other similar names. By focusing on molecular and cellular changes that are specific to cancer, targeted cancer therapies may be more effective than current treatments and less harmful to normal cells.

Most targeted cancer therapies are in preclinical testing (research with animals), but some are in clinical trials (research studies with people), or have been approved by the U.S. Food and Drug Administration (FDA). Targeted cancer therapies are being studied for use alone, in combination with each other, and in combination with other cancer treatments, such as chemotherapy.

More from the National Cancer Institute